2020
▪Launched ¡°Bicrome¡± for nose-care probiotics
of NVP-1703 in Korea
▪Signed a license-out agreement of NVP-1102 in Russia
▪Approved IND for clinical trial phase III of NVP-1805
2019
▪Approved IND for clinical trial phase III of NVP-1203
▪Launched NVP-1503 in Korea
▪Obtained individual recognition of functional ingredient
for NVP-1703 from MFDS
▪Initiated human study of functional probiotics
for NVP-1905
2018
▪Initiated human study of functional probiotics
for NVP-1704
▪Obtained Exclusive Marketing Approval
of NVP-1504 from MFDS
2017
▪Designated as ¡°Pharmaceutical Testing Laboratory¡±
by MFDS
▪Initiated human study of functional probiotics
for NVP-1702
▪Initiated human study of functional probiotics
for NVP-1703